Affiliation:
1. Department of Medicine and Health Sciences, University of Molise, 86100 Campobasso, Italy
Abstract
Frailty is a clinical condition closely related to aging which is characterized by a multidimensional decline in biological reserves, a failure of physiological mechanisms and vulnerability to minor stressors. Chronic inflammation, the impairment of endothelial function, age-related endocrine system modifications and immunosenescence are important mechanisms in the pathophysiology of frailty. Endothelial progenitor cells (EPCs) are considered important contributors of the endothelium homeostasis and turn-over. In the elderly, EPCs are impaired in terms of function, number and survival. In addition, the modification of EPCs’ level and function has been widely demonstrated in atherosclerosis, hypertension and diabetes mellitus, which are the most common age-related diseases. The purpose of this review is to illustrate the role of EPCs in frailty. Initially, we describe the endothelial dysfunction in frailty, the response of EPCs to the endothelial dysfunction associated with frailty and, finally, interventions which may restore the EPCs expression and function in frail people.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference130 articles.
1. United Nations Department of Economic and Social Affairs Population Division (2020). World Population Ageing 2020 Highlights: Living Arrangements of Older Persons, United Nations. (ST/ESA/SER.A/451).
2. United Nations Department of Economic and Social Affairs Population Division (2019). World Population Ageing 2019: Highlights, United Nations. (ST/ESA/SER.A/430).
3. Frailty in elderly people;Clegg;Lancet,2013
4. Frailty: Is This a New Vital Sign?;Cicutto;Chest,2018
5. Frailty and Risk of Adverse Outcomes in Hospitalized Older Adults: A Comparison of Different Frailty Measures;Chong;J. Am. Med. Dir. Assoc.,2017